 | • レポートコード：MRC2-11QY10445 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は全身性肥満細胞症治療のグローバル市場について調査・分析したレポートです。種類別（AK-002、BLU-285、ブレンツキシマブベドチン、ベシル酸クレノラニブ、クロモリンナトリウム、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別全身性肥満細胞症治療の競争状況、市場シェア ・世界の全身性肥満細胞症治療市場：種類別市場規模 2015年-2020年（AK-002、BLU-285、ブレンツキシマブベドチン、ベシル酸クレノラニブ、クロモリンナトリウム、その他） ・世界の全身性肥満細胞症治療市場：種類別市場規模予測 2021年-2026年（AK-002、BLU-285、ブレンツキシマブベドチン、ベシル酸クレノラニブ、クロモリンナトリウム、その他） ・世界の全身性肥満細胞症治療市場：用途別市場規模 2015年-2020年（クリニック、病院、在宅医療） ・世界の全身性肥満細胞症治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、在宅医療） ・北米の全身性肥満細胞症治療市場分析：米国、カナダ ・ヨーロッパの全身性肥満細胞症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの全身性肥満細胞症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の全身性肥満細胞症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの全身性肥満細胞症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AB Science SA、AbbVie Inc、Arog Pharmaceuticals Inc、Blueprint Medicines Corp、Bristol-Myers Squibb Company、Deciphera Pharmaceuticals LLC、Novartis AG、Patara Pharma Inc、Seattle Genetics Inc、Stemline Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Systemic Mastocytosis Treatment Market
The global Systemic Mastocytosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Systemic Mastocytosis Treatment Scope and Market Size
Systemic Mastocytosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Mastocytosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Systemic Mastocytosis Treatment market is segmented into
AK-002
BLU-285
Brentuximab Vedotin
Crenolanib Besylate
Cromolyn Sodium
Others
Segment by Application, the Systemic Mastocytosis Treatment market is segmented into
Clinic
Hospital
Homecare
Regional and Country-level Analysis
The Systemic Mastocytosis Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Systemic Mastocytosis Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Systemic Mastocytosis Treatment Market Share Analysis
Systemic Mastocytosis Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Systemic Mastocytosis Treatment business, the date to enter into the Systemic Mastocytosis Treatment market, Systemic Mastocytosis Treatment product introduction, recent developments, etc.
The major vendors covered:
AB Science SA
AbbVie Inc
Arog Pharmaceuticals Inc
Blueprint Medicines Corp
Bristol-Myers Squibb Company
Deciphera Pharmaceuticals LLC
Novartis AG
Patara Pharma Inc
Seattle Genetics Inc
Stemline Therapeutics Inc
1 Study Coverage
1.1 Systemic Mastocytosis Treatment Product Introduction
1.2 Market Segments
1.3 Key Systemic Mastocytosis Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Systemic Mastocytosis Treatment Market Size Growth Rate by Type
1.4.2 AK-002
1.4.3 BLU-285
1.4.4 Brentuximab Vedotin
1.4.5 Crenolanib Besylate
1.4.6 Cromolyn Sodium
1.4.7 Others
1.5 Market by Application
1.5.1 Global Systemic Mastocytosis Treatment Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Systemic Mastocytosis Treatment Market Size, Estimates and Forecasts
2.1.1 Global Systemic Mastocytosis Treatment Revenue 2015-2026
2.1.2 Global Systemic Mastocytosis Treatment Sales 2015-2026
2.2 Global Systemic Mastocytosis Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Systemic Mastocytosis Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Systemic Mastocytosis Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Systemic Mastocytosis Treatment Competitor Landscape by Players
3.1 Systemic Mastocytosis Treatment Sales by Manufacturers
3.1.1 Systemic Mastocytosis Treatment Sales by Manufacturers (2015-2020)
3.1.2 Systemic Mastocytosis Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Systemic Mastocytosis Treatment Revenue by Manufacturers
3.2.1 Systemic Mastocytosis Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Systemic Mastocytosis Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Systemic Mastocytosis Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Systemic Mastocytosis Treatment Revenue in 2019
3.2.5 Global Systemic Mastocytosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Systemic Mastocytosis Treatment Price by Manufacturers
3.4 Systemic Mastocytosis Treatment Manufacturing Base Distribution, Product Types
3.4.1 Systemic Mastocytosis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Systemic Mastocytosis Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Systemic Mastocytosis Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Systemic Mastocytosis Treatment Market Size by Type (2015-2020)
4.1.1 Global Systemic Mastocytosis Treatment Sales by Type (2015-2020)
4.1.2 Global Systemic Mastocytosis Treatment Revenue by Type (2015-2020)
4.1.3 Systemic Mastocytosis Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Systemic Mastocytosis Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Systemic Mastocytosis Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Systemic Mastocytosis Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Systemic Mastocytosis Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Systemic Mastocytosis Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Systemic Mastocytosis Treatment Market Size by Application (2015-2020)
5.1.1 Global Systemic Mastocytosis Treatment Sales by Application (2015-2020)
5.1.2 Global Systemic Mastocytosis Treatment Revenue by Application (2015-2020)
5.1.3 Systemic Mastocytosis Treatment Price by Application (2015-2020)
5.2 Systemic Mastocytosis Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Systemic Mastocytosis Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Systemic Mastocytosis Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Systemic Mastocytosis Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Systemic Mastocytosis Treatment by Country
6.1.1 North America Systemic Mastocytosis Treatment Sales by Country
6.1.2 North America Systemic Mastocytosis Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Systemic Mastocytosis Treatment Market Facts & Figures by Type
6.3 North America Systemic Mastocytosis Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Systemic Mastocytosis Treatment by Country
7.1.1 Europe Systemic Mastocytosis Treatment Sales by Country
7.1.2 Europe Systemic Mastocytosis Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Systemic Mastocytosis Treatment Market Facts & Figures by Type
7.3 Europe Systemic Mastocytosis Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Systemic Mastocytosis Treatment by Region
8.1.1 Asia Pacific Systemic Mastocytosis Treatment Sales by Region
8.1.2 Asia Pacific Systemic Mastocytosis Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Systemic Mastocytosis Treatment Market Facts & Figures by Type
8.3 Asia Pacific Systemic Mastocytosis Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Systemic Mastocytosis Treatment by Country
9.1.1 Latin America Systemic Mastocytosis Treatment Sales by Country
9.1.2 Latin America Systemic Mastocytosis Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Systemic Mastocytosis Treatment Market Facts & Figures by Type
9.3 Central & South America Systemic Mastocytosis Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Systemic Mastocytosis Treatment by Country
10.1.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Country
10.1.2 Middle East and Africa Systemic Mastocytosis Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Systemic Mastocytosis Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Systemic Mastocytosis Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 AB Science SA
11.1.1 AB Science SA Corporation Information
11.1.2 AB Science SA Description and Business Overview
11.1.3 AB Science SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science SA Systemic Mastocytosis Treatment Products Offered
11.1.5 AB Science SA Related Developments
11.2 AbbVie Inc
11.2.1 AbbVie Inc Corporation Information
11.2.2 AbbVie Inc Description and Business Overview
11.2.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AbbVie Inc Systemic Mastocytosis Treatment Products Offered
11.2.5 AbbVie Inc Related Developments
11.3 Arog Pharmaceuticals Inc
11.3.1 Arog Pharmaceuticals Inc Corporation Information
11.3.2 Arog Pharmaceuticals Inc Description and Business Overview
11.3.3 Arog Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Products Offered
11.3.5 Arog Pharmaceuticals Inc Related Developments
11.4 Blueprint Medicines Corp
11.4.1 Blueprint Medicines Corp Corporation Information
11.4.2 Blueprint Medicines Corp Description and Business Overview
11.4.3 Blueprint Medicines Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Blueprint Medicines Corp Systemic Mastocytosis Treatment Products Offered
11.4.5 Blueprint Medicines Corp Related Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Corporation Information
11.5.2 Bristol-Myers Squibb Company Description and Business Overview
11.5.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Products Offered
11.5.5 Bristol-Myers Squibb Company Related Developments
11.6 Deciphera Pharmaceuticals LLC
11.6.1 Deciphera Pharmaceuticals LLC Corporation Information
11.6.2 Deciphera Pharmaceuticals LLC Description and Business Overview
11.6.3 Deciphera Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Products Offered
11.6.5 Deciphera Pharmaceuticals LLC Related Developments
11.7 Novartis AG
11.7.1 Novartis AG Corporation Information
11.7.2 Novartis AG Description and Business Overview
11.7.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis AG Systemic Mastocytosis Treatment Products Offered
11.7.5 Novartis AG Related Developments
11.8 Patara Pharma Inc
11.8.1 Patara Pharma Inc Corporation Information
11.8.2 Patara Pharma Inc Description and Business Overview
11.8.3 Patara Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Patara Pharma Inc Systemic Mastocytosis Treatment Products Offered
11.8.5 Patara Pharma Inc Related Developments
11.9 Seattle Genetics Inc
11.9.1 Seattle Genetics Inc Corporation Information
11.9.2 Seattle Genetics Inc Description and Business Overview
11.9.3 Seattle Genetics Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Seattle Genetics Inc Systemic Mastocytosis Treatment Products Offered
11.9.5 Seattle Genetics Inc Related Developments
11.10 Stemline Therapeutics Inc
11.10.1 Stemline Therapeutics Inc Corporation Information
11.10.2 Stemline Therapeutics Inc Description and Business Overview
11.10.3 Stemline Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Products Offered
11.10.5 Stemline Therapeutics Inc Related Developments
11.1 AB Science SA
11.1.1 AB Science SA Corporation Information
11.1.2 AB Science SA Description and Business Overview
11.1.3 AB Science SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science SA Systemic Mastocytosis Treatment Products Offered
11.1.5 AB Science SA Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Systemic Mastocytosis Treatment Market Estimates and Projections by Region
12.1.1 Global Systemic Mastocytosis Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Systemic Mastocytosis Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Systemic Mastocytosis Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Systemic Mastocytosis Treatment Sales Forecast (2021-2026)
12.2.2 North America: Systemic Mastocytosis Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Systemic Mastocytosis Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Systemic Mastocytosis Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Systemic Mastocytosis Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Systemic Mastocytosis Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Systemic Mastocytosis Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Systemic Mastocytosis Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Systemic Mastocytosis Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Systemic Mastocytosis Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Systemic Mastocytosis Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Systemic Mastocytosis Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Systemic Mastocytosis Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Systemic Mastocytosis Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Systemic Mastocytosis Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Systemic Mastocytosis Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Systemic Mastocytosis Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Systemic Mastocytosis Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Systemic Mastocytosis Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Systemic Mastocytosis Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Systemic Mastocytosis Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Systemic Mastocytosis Treatment Market Segments
Table 2. Ranking of Global Top Systemic Mastocytosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Systemic Mastocytosis Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AK-002
Table 5. Major Manufacturers of BLU-285
Table 6. Major Manufacturers of Brentuximab Vedotin
Table 7. Major Manufacturers of Crenolanib Besylate
Table 8. Major Manufacturers of Cromolyn Sodium
Table 9. Major Manufacturers of Others
Table 10. Global Systemic Mastocytosis Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Systemic Mastocytosis Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Systemic Mastocytosis Treatment Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Systemic Mastocytosis Treatment Sales Market Share by Regions (2015-2020)
Table 14. Global Systemic Mastocytosis Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Systemic Mastocytosis Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Systemic Mastocytosis Treatment Sales Share by Manufacturers (2015-2020)
Table 17. Global Systemic Mastocytosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Systemic Mastocytosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Mastocytosis Treatment as of 2019)
Table 19. Systemic Mastocytosis Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Systemic Mastocytosis Treatment Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Systemic Mastocytosis Treatment Price (2015-2020) (USD/Pcs)
Table 22. Systemic Mastocytosis Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Systemic Mastocytosis Treatment Product Type
Table 24. Date of International Manufacturers Enter into Systemic Mastocytosis Treatment Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Mastocytosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 27. Global Systemic Mastocytosis Treatment Sales Share by Type (2015-2020)
Table 28. Global Systemic Mastocytosis Treatment Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Systemic Mastocytosis Treatment Revenue Share by Type (2015-2020)
Table 30. Systemic Mastocytosis Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Systemic Mastocytosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 32. Global Systemic Mastocytosis Treatment Sales Share by Application (2015-2020)
Table 33. North America Systemic Mastocytosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 34. North America Systemic Mastocytosis Treatment Sales Market Share by Country (2015-2020)
Table 35. North America Systemic Mastocytosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Systemic Mastocytosis Treatment Revenue Market Share by Country (2015-2020)
Table 37. North America Systemic Mastocytosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 38. North America Systemic Mastocytosis Treatment Sales Market Share by Type (2015-2020)
Table 39. North America Systemic Mastocytosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 40. North America Systemic Mastocytosis Treatment Sales Market Share by Application (2015-2020)
Table 41. Europe Systemic Mastocytosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Systemic Mastocytosis Treatment Sales Market Share by Country (2015-2020)
Table 43. Europe Systemic Mastocytosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Systemic Mastocytosis Treatment Revenue Market Share by Country (2015-2020)
Table 45. Europe Systemic Mastocytosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Systemic Mastocytosis Treatment Sales Market Share by Type (2015-2020)
Table 47. Europe Systemic Mastocytosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Systemic Mastocytosis Treatment Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Systemic Mastocytosis Treatment Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Systemic Mastocytosis Treatment Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Systemic Mastocytosis Treatment Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Systemic Mastocytosis Treatment Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Systemic Mastocytosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Systemic Mastocytosis Treatment Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Systemic Mastocytosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Systemic Mastocytosis Treatment Sales Market Share by Application (2015-2020)
Table 57. Latin America Systemic Mastocytosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Systemic Mastocytosis Treatment Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Systemic Mastocytosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Systemic Mastocytosis Treatment Revenue Market Share by Country (2015-2020)
Table 61. Latin America Systemic Mastocytosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Systemic Mastocytosis Treatment Sales Market Share by Type (2015-2020)
Table 63. Latin America Systemic Mastocytosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Systemic Mastocytosis Treatment Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Systemic Mastocytosis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Systemic Mastocytosis Treatment Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Systemic Mastocytosis Treatment Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Systemic Mastocytosis Treatment Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Application (2015-2020)
Table 73. AB Science SA Corporation Information
Table 74. AB Science SA Description and Major Businesses
Table 75. AB Science SA Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. AB Science SA Product
Table 77. AB Science SA Recent Development
Table 78. AbbVie Inc Corporation Information
Table 79. AbbVie Inc Description and Major Businesses
Table 80. AbbVie Inc Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. AbbVie Inc Product
Table 82. AbbVie Inc Recent Development
Table 83. Arog Pharmaceuticals Inc Corporation Information
Table 84. Arog Pharmaceuticals Inc Description and Major Businesses
Table 85. Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Arog Pharmaceuticals Inc Product
Table 87. Arog Pharmaceuticals Inc Recent Development
Table 88. Blueprint Medicines Corp Corporation Information
Table 89. Blueprint Medicines Corp Description and Major Businesses
Table 90. Blueprint Medicines Corp Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Blueprint Medicines Corp Product
Table 92. Blueprint Medicines Corp Recent Development
Table 93. Bristol-Myers Squibb Company Corporation Information
Table 94. Bristol-Myers Squibb Company Description and Major Businesses
Table 95. Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Bristol-Myers Squibb Company Product
Table 97. Bristol-Myers Squibb Company Recent Development
Table 98. Deciphera Pharmaceuticals LLC Corporation Information
Table 99. Deciphera Pharmaceuticals LLC Description and Major Businesses
Table 100. Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Deciphera Pharmaceuticals LLC Product
Table 102. Deciphera Pharmaceuticals LLC Recent Development
Table 103. Novartis AG Corporation Information
Table 104. Novartis AG Description and Major Businesses
Table 105. Novartis AG Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Novartis AG Product
Table 107. Novartis AG Recent Development
Table 108. Patara Pharma Inc Corporation Information
Table 109. Patara Pharma Inc Description and Major Businesses
Table 110. Patara Pharma Inc Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Patara Pharma Inc Product
Table 112. Patara Pharma Inc Recent Development
Table 113. Seattle Genetics Inc Corporation Information
Table 114. Seattle Genetics Inc Description and Major Businesses
Table 115. Seattle Genetics Inc Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Seattle Genetics Inc Product
Table 117. Seattle Genetics Inc Recent Development
Table 118. Stemline Therapeutics Inc Corporation Information
Table 119. Stemline Therapeutics Inc Description and Major Businesses
Table 120. Stemline Therapeutics Inc Systemic Mastocytosis Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Stemline Therapeutics Inc Product
Table 122. Stemline Therapeutics Inc Recent Development
Table 123. Global Systemic Mastocytosis Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 124. Global Systemic Mastocytosis Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Systemic Mastocytosis Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Systemic Mastocytosis Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Systemic Mastocytosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. North America: Systemic Mastocytosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Systemic Mastocytosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Europe: Systemic Mastocytosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Systemic Mastocytosis Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 132. Asia Pacific: Systemic Mastocytosis Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Systemic Mastocytosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Latin America: Systemic Mastocytosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Systemic Mastocytosis Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. Middle East and Africa: Systemic Mastocytosis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Systemic Mastocytosis Treatment Players
Table 141. Systemic Mastocytosis Treatment Customers List
Table 142. Systemic Mastocytosis Treatment Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Systemic Mastocytosis Treatment Product Picture
Figure 2. Global Systemic Mastocytosis Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. AK-002 Product Picture
Figure 4. BLU-285 Product Picture
Figure 5. Brentuximab Vedotin Product Picture
Figure 6. Crenolanib Besylate Product Picture
Figure 7. Cromolyn Sodium Product Picture
Figure 8. Others Product Picture
Figure 9. Global Systemic Mastocytosis Treatment Sales Market Share by Application in 2020 & 2026
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Homecare
Figure 13. Systemic Mastocytosis Treatment Report Years Considered
Figure 14. Global Systemic Mastocytosis Treatment Market Size 2015-2026 (US$ Million)
Figure 15. Global Systemic Mastocytosis Treatment Sales 2015-2026 (K Pcs)
Figure 16. Global Systemic Mastocytosis Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Systemic Mastocytosis Treatment Sales Market Share by Region (2015-2020)
Figure 18. Global Systemic Mastocytosis Treatment Sales Market Share by Region in 2019
Figure 19. Global Systemic Mastocytosis Treatment Revenue Market Share by Region (2015-2020)
Figure 20. Global Systemic Mastocytosis Treatment Revenue Market Share by Region in 2019
Figure 21. Global Systemic Mastocytosis Treatment Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Systemic Mastocytosis Treatment Revenue in 2019
Figure 23. Systemic Mastocytosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Systemic Mastocytosis Treatment Sales Market Share by Type (2015-2020)
Figure 25. Global Systemic Mastocytosis Treatment Sales Market Share by Type in 2019
Figure 26. Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2015-2020)
Figure 27. Global Systemic Mastocytosis Treatment Revenue Market Share by Type in 2019
Figure 28. Global Systemic Mastocytosis Treatment Market Share by Price Range (2015-2020)
Figure 29. Global Systemic Mastocytosis Treatment Sales Market Share by Application (2015-2020)
Figure 30. Global Systemic Mastocytosis Treatment Sales Market Share by Application in 2019
Figure 31. Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2015-2020)
Figure 32. Global Systemic Mastocytosis Treatment Revenue Market Share by Application in 2019
Figure 33. North America Systemic Mastocytosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Systemic Mastocytosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Systemic Mastocytosis Treatment Sales Market Share by Country in 2019
Figure 36. North America Systemic Mastocytosis Treatment Revenue Market Share by Country in 2019
Figure 37. U.S. Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Systemic Mastocytosis Treatment Market Share by Type in 2019
Figure 42. North America Systemic Mastocytosis Treatment Market Share by Application in 2019
Figure 43. Europe Systemic Mastocytosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Systemic Mastocytosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Systemic Mastocytosis Treatment Sales Market Share by Country in 2019
Figure 46. Europe Systemic Mastocytosis Treatment Revenue Market Share by Country in 2019
Figure 47. Germany Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Systemic Mastocytosis Treatment Market Share by Type in 2019
Figure 58. Europe Systemic Mastocytosis Treatment Market Share by Application in 2019
Figure 59. Asia Pacific Systemic Mastocytosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Systemic Mastocytosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Systemic Mastocytosis Treatment Sales Market Share by Region in 2019
Figure 62. Asia Pacific Systemic Mastocytosis Treatment Revenue Market Share by Region in 2019
Figure 63. China Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Systemic Mastocytosis Treatment Market Share by Type in 2019
Figure 86. Asia Pacific Systemic Mastocytosis Treatment Market Share by Application in 2019
Figure 87. Latin America Systemic Mastocytosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Systemic Mastocytosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Systemic Mastocytosis Treatment Sales Market Share by Country in 2019
Figure 90. Latin America Systemic Mastocytosis Treatment Revenue Market Share by Country in 2019
Figure 91. Mexico Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Systemic Mastocytosis Treatment Market Share by Type in 2019
Figure 98. Latin America Systemic Mastocytosis Treatment Market Share by Application in 2019
Figure 99. Middle East and Africa Systemic Mastocytosis Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Systemic Mastocytosis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Systemic Mastocytosis Treatment Revenue Market Share by Country in 2019
Figure 103. Turkey Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Systemic Mastocytosis Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Systemic Mastocytosis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Systemic Mastocytosis Treatment Market Share by Type in 2019
Figure 110. Middle East and Africa Systemic Mastocytosis Treatment Market Share by Application in 2019
Figure 111. North America Systemic Mastocytosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Systemic Mastocytosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Systemic Mastocytosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Systemic Mastocytosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Systemic Mastocytosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Systemic Mastocytosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Systemic Mastocytosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Systemic Mastocytosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Systemic Mastocytosis Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Systemic Mastocytosis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
皮膚肥満細胞症の世界市場（～2026年） Mastocytosis is rare condition characterized by excessive accumulation of mast cells in the body tissues. Mast cells release large amounts of histamine in blood which leads to itchy skin, skin rash and hot flushes. These cells are found in skin and the lining of stomach and lungs. Mast cells accumul…- 全身感染症治療の世界市場（～2026年） Systemic infection earns its name by being spread throughout the systems of the body. Systemic infections are not necessarily more severe than local infections. Market Analysis and Insights: Global Systemic Infection Treatment Market The global Systemic Infection Treatment market size is projected t…
- 全身性特発性若年性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Systemic Idiopath…
- 全身性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcoho…
- 全身性エリテマトーデス（SLE）治療薬の世界市場（～2026年） SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …